Principal investigator
|
|
 |
Quote
"My dream is to contribute to a quantum change in cancer treatment",
explains Professor Bruce Baguley.
|
Research interests
Our main aim is to develop improved treatments for cancer patients. This aim is
pursued firstly by the development of new anticancer drugs to the point of clinical
trial, and secondly by basic research aimed at tailoring existing treatment to the
individual cancer patient. In drug development, the Tumour Biology Group interfaces
with the Medicinal Chemistry Group
and concentrates particularly on cellular and
pharmacological aspects of drug development. In basic research, we collaborate with
surgeons and oncologists to examine tumour material taken from individual cancer
patients.
Medicinal Chemistry Group
Current areas of research
Group members
Top